U S LABORATORIES INC (CIK: 0001068891) EDGAR, Information, Filings... CompaniesBIO.Com

U S LABORATORIES INC

Mailing address
7895 CONVOY COURT, SUITE 18, SAN DIEGO, Delaware, 92111
Phone
8587155800
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES
Filings
N/A

U S LABORATORIES INC (CIK: 0001068891) is an American company incorporated in the state of California. Head office is located at 7895 CONVOY COURT, SUITE 18, SAN DIEGO, California, 92111. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. U S LABORATORIES INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by U S LABORATORIES INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001056568-03-000068 ( Act) Size: KB	Feb-14-2003	005-55917 03567672
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950120-02-000592 ( Act) Size: KB	Nov-08-2002	000-25339 02813668
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001017062-02-001668 ( Act) Size: KB	Sep-25-2002	005-55917 02772214
SC 14D9/A	Document	Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9 Acc-no: 0001017062-02-001664 ( Act) Size: KB	Sep-24-2002	005-55917 02771226
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000807249-02-000259 ( Act) Size: KB	Sep-24-2002	005-55917 02771219
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000807249-02-000257 ( Act) Size: 0 KB	Sep-23-2002	000-25339 02769946
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000807249-02-000254 ( Act) Size: 0 KB	Sep-20-2002	000-25339 02768673
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950130-02-006642 ( Act) Size: KB	Sep-20-2002	005-55917 02768509
SC 14D9/A	Document	Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9 Acc-no: 0001017062-02-001639 ( Act) Size: KB	Sep-16-2002	005-55917 02764385
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950130-02-006541 ( Act) Size: KB	Sep-13-2002	005-55917 02764243
SC 14D9/A	Document	Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9 Acc-no: 0000898430-02-003435 ( Act) Size: KB	Sep-13-2002	005-55917 02762987
SC14D9C	Document	Written communication by the subject company relating to a third party tender offer Acc-no: 0001017062-02-001616 ( Act) Size: KB	Sep-09-2002	005-55917 02759035
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000807249-02-000235 ( Act) Size: KB	Aug-30-2002	005-55917 02754710
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000950130-02-006330 ( Act) Size: 0 KB	Aug-30-2002	000-25339 02754650
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950130-02-006329 ( Act) Size: KB	Aug-30-2002	005-55917 02754643
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000807249-02-000231 ( Act) Size: KB	Aug-29-2002	005-55917 02752194
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001017062-02-001595 ( Act) Size: KB	Aug-28-2002	005-55917 02751619
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950130-02-006206 ( Act) Size: KB	Aug-26-2002	005-55917 02747844
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000807249-02-000222 ( Act) Size: KB	Aug-22-2002	005-55917 02746132
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000807249-02-000221 ( Act) Size: KB	Aug-22-2002	005-55917 02746059

Recent 20 filings. View all U S LABORATORIES INC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

U S LABORATORIES INC overview
U S LABORATORIES INC job
U S LABORATORIES INC stock
U S LABORATORIES INC ownership
U S LABORATORIES INC CEO
U S LABORATORIES INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.